We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...
We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR ...
Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...
Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
10h
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth KnowingCRISPR Therapeutics AG (CRSP) closed the latest trading day at $41.22, indicating a +0.12% change from the previous session's end. This change outpaced the S&P 500's 0.08% gain on the day. On the ...
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
Cathie Wood’s ARK Invest is taking advantage of the recent dip in Tesla (TSLA) stock by purchasing 9,351 shares through its ARKK ETF (ARKK), ...
Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
A month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 0.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results